<DOC>
	<DOCNO>NCT01224938</DOCNO>
	<brief_summary>The main objective study 1. study different T cell subtypes ( Th1 , Th2 , Th17 Treg ) low airways healthy subject clinically different asthma patient , base non-invasive procedure sputum induction . Patients different function age , relation trigger ( eg aspirin , without association polyposis ) , without underlie atopic sensitization different type underlie inflammation ( eosinophilic v neutrophilic ) . This T cell pattern become basis molecular phenotyping patient . 2. study usefulness asthma molecular phenotyping ( follow balance inflammatory marker one hand regulatory marker hand ) asthma guidance ( longitudinally ) . The final goal project develop sputum non-invasive biomarker array use distinguish different inflammatory asthma phenotype predict steroid resistance and/or sensitivity anti-inflammatory medication , use non-invasive technique use also young age repetitively .</brief_summary>
	<brief_title>Development Validation Sputum Biomarker mRNA Panel Diagnostic Work-up Asthma 1 .</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>asthma diagnosis viral/bacterial/fungal infection fever ( &lt; 1 month ) airway disease ( CF , ciliar dyskinesia , bronchiectasis ) asthma exacerbation ( &lt; 3 month )</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>